Last Updated: June 22, 2026

EDETATE Drug Patent Profile

Name: EDETATE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Edetate patents expire, and what generic alternatives are available?

Edetate is a drug marketed by Casper Pharma Llc and is included in one NDA.

The generic ingredient in EDETATE is edetate calcium disodium. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the edetate calcium disodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Edetate

A generic version of EDETATE was approved as edetate calcium disodium by CASPER PHARMA LLC on May 3^rd, 2023.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for EDETATE?
What are the global sales for EDETATE?
What is Average Wholesale Price for EDETATE?

Summary for EDETATE

US Patents:	0
Applicants:	1
NDAs:	1
Drug Prices:	Drug price information for EDETATE
DailyMed Link:	EDETATE at DailyMed

Drug patent expirations by year for EDETATE

US Patents and Regulatory Information for EDETATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Casper Pharma Llc	EDETATE CALCIUM DISODIUM	edetate calcium disodium	INJECTABLE;INJECTION	216435-001	May 3, 2023		RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for EDETATE

Edetate calcium disodium cost?
Edetate calcium disodium price?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.